TuisNVTAQ • OTCMKTS
add
Invitae Corp
Vorige sluiting
$0,0020
Dagwisseling
$0,00070 - $0,0011
Markkapitalisasie
28,36 k USD
Gemiddelde volume
266,91 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
OTCMKTS
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2023info | J/J-verandering |
|---|---|---|
Inkomste | 121,24 m | -9,21% |
Bedryfskoste | 141,95 m | -21,71% |
Netto inkomste | -942,11 m | -212,83% |
Netto winsgrens | -777,05 | -244,56% |
Wins per aandeel | -0,10 | 76,19% |
EBITDA | -71,16 m | 42,73% |
Effektiewe belastingkoers | 0,65% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2023info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 254,57 m | -56,55% |
Totale bates | 535,12 m | -73,59% |
Totale aanspreeklikheid | 1,62 mjd | -13,33% |
Totale ekwiteit | -1,08 mjd | — |
Uitstaande aandele | 286,49 m | — |
Prys om te bespreek | -0,00 | — |
Opbrengs op bates | -25,00% | — |
Opbrengs op kapitaal | -28,48% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2023info | J/J-verandering |
|---|---|---|
Netto inkomste | -942,11 m | -212,83% |
Kontant van bedrywe | -66,90 m | 48,02% |
Kontant van beleggings | 5,12 m | -88,32% |
Kontant van finansiering | -3,38 m | -99,94% |
Netto kontantverandering | -65,16 m | 24,76% |
Beskikbare kontantvloei | -29,46 m | -38,14% |
Meer oor
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
In early 2024, Invitae filed for Chapter 11 bankruptcy protection, and later announced an agreement for an acquisition by Labcorp. Wikipedia
Gestig
2010
Webwerf
Werknemers
1 700
